This is LU Bio

Lean and swift

| Print |

Tell a colleague

Tell a colleague about this

Your name

Recipient E-mail

Share this page

Windows Live

Facebook

Google Bookmarks

del.icio.us

digg

FriendFeed

MySpace

LU Bio has a sharp commercial focus and our goal is to develop innovations and create value growth for all parties involved – inventors, investors, Lund University and society at large. To remain lean and swift, we have a slimmed and experienced management, and an extensive network of industry specialists and consultants. We function as a virtual company to be cost- and time-effective.

Thomas Andersson, CEO

Born 1952.
MSc in chemistry and PhD in biophysics from Lund University.
25 years experience from early-stage bioscience companies.
Active within Karolinska Institute´s innovation system since 2000.
Senior Adviser Karolinska Innovations and Investment Manager in Karolinska Development I and II.

Eskil Söderlind, Investment Director

Born 1959.
PhD in molecular biology from Uppsala University. Executive MBA diploma and associate professor at Lund University.
More than 20 years experience from the bioscience/biotech area.
He has held different management positions that have resulted in several inventions of platform technologies at established companies.

Per-Ola Forsberg, CFO

Born 1961.
Degree in economics and business administration from Lund University. CFO and Executive Vice President in Probi AB 2000-2008. Prior to this, he was the Controller at Rexam Beverage Can Fosie AB, and earlier he was Head of Administration at PolyPeptide Laboratories AB, a subsidiary of Ferring AB.

+46 (0)46 286 48 20
info@lubio.se

Ideon, Alfa 5
SE 223 70 Lund, Sweden

Lund University Bioscience AB